All In MedTech

Device Trial Radar · NCT02412709

Long QT Syndrome Screening in Newborns

ECG Device for Long QT Syndrome Screening in Newborns

Last checked: Nov 20, 2026Latest source record: Sep 28, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 4,000 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

4,000

Planned (sponsor's estimate)

Start

Jun 2015

Primary completion

Dec 2016

Study completion Mar 2017

Sponsor

Lead sponsor
QT Medical, Inc.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; University of California, Irvine
First posted
Apr 9, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Screening
Who can join
All sexes, from 2 weeks, up to 4 weeks
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this project is to test a new, very compact, 12-lead ECG device as a way to detect long QT syndrome (LQTS) in infants. The device -- called QTScreen -- was developed in Phase I of this project. In Phase II, the goals are to test the capacity of the device for LQTS screening in newborns and to obtain prevalence data on LQTS in California. The 4 main objectives are: 1. To validate the capacity of QTScreen for LQTS screening in newborns. 2. To determine the extent to which parents are able to use QTScreen on their babies at home. 3. To survey end-user experience and opinions. 4. To estimate the LQTS prevalence in California.

Conditions

  • Long QT Syndrome

Interventions

  • QTScreen ECG RecorderDevice

    Subjects will be randomly assigned to the: Parents Performing ECG (PPE) group or Staff Performing ECG (SPE) group. This will assess whether parents are able to use QTScreen on babies at home.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determine LQTS risk via QTc Measurement and family/personal historyTime frame: within 1-2 business days after QTScreen recording

1 more outcomes with a free account

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • St. Francis Medical Center

    Lynwood, California · Recruiting

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.